<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211012052742N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-10-19</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>The effect of laser therapy on the treatment of partial tear of the supraspinatus tendon</public_title>
      <acronym></acronym>
      <scientific_title>A comparative study of the effects of low and high power laser therapy in partial tear of the supraspinatus tendon with use of ultrasonography in 20 to 40 years old subjects with shoulder pain.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-10-30</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59301</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In order to maintain the balance of the number of samples in the two groups and the homogeneity of the samples in the groups, we first divide the patients into four homogeneous classes based on age, sex and location of injury.
Then, using the permutation block method, patients are randomly assigned to two treatment groups, Blinding description: Blinding will be done for the participant, evaluator and data analyzer. Patients will be randomly divided into two groups. Low power and high power laser will be used in the intervention. Patients will not know which treatment group they are in. The evaluation is also performed by a person who is not aware of the patients in each group. Finally, we provide the groups to the statistical analyzer as a blind.</study_design>
      <phase>3</phase>
      <hc_freetext>partial tear of supraspinatus tendon.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Intervention group: At the beginning of the treatment session, people undergoing cold therapy were placed on the shoulder area for 10 to 15 minutes using an ice pack. Then, in the first group, citing the World Laser Therapy Association (WALT) on the properties of the most effective low-power laser parameters in supraspinatus tendinopathy, under low-power IR laser therapy with a wavelength of 810 nm are significant. According to the proposed WALT protocol, the laser is applied at 2 to 3 points at the site of supraspinatus muscle tendon insertion and the former acromial space, with a high energy content of 4 gels per square meter, and generally 12 joules of energy during treatment. The patient's position is sitting and the hand is in the adduction position during the laser application. Pendulum exercises and range of motion improvements from the initial sessions, and isometric strengthening exercises from the fifth session, were added to the treatment program. in order to observe safety during laser treatment, although the risk of eye injury is small, precautions for using the laser are observed. Intervention 2: Intervention group:Intervention group: At the beginning of the treatment session, people undergoing cryotherapy are placed on the shoulder region for 10 to 15 minutes using an ice pack. In this group, a laser with a power of 8 watts, energy of 12 joules per square centimeter and total energy of 10,000 joules will be used for about 15 minutes. The percussion of each pulse will be 150 microseconds and the frequency of 30 Hz in the first and third phases and the frequency of 25-25 Hz in the second phase will be used in an area of ​​25 cm2 during the three phases. The initial phase is applied in front of the shoulder joint line, with 850 mJ of energy per shot and at a frequency of 30 Hz. Total energy applied in this phase is equal to 4000 joules. In the second phase, the energy of each pulse is equal to 350 mJ and with a frequency of 20-25 Hz in front and behind the shoulder joint line. The total energy of this phase is equal to 4000 joules. In the third phase, which is applied in the same place as the first phase as well as the deltoid muscle areas, a total energy of 2000 joules is radiated. In general, the time required for laser treatment in all three phases of treatment will be about 15 minutes. And how to use the laser is rapid manual scanning. A spacer with a diameter of 35 mm will also be used to ensure a constant distance between the applicator and the skin during laser treatment. The patient's position during the laser application is sitting with the affected hand in the adduction position. Pendulum exercises and range of motion improvements from the initial sessions, and isometric strengthening exercises from the fifth session are added to the treatment program.  in order to observe safety during laser treatment, although the risk of eye injury is small, precautions for using the laser are observed.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>َAli Khoshdel</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 27, West zayande rod Ave, North shirazi Ave, Mollasadre Ave, vanak square</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1991613651</zip>
        <telephone>+98 58 3224 4488</telephone>
        <email>alikhoshdel97@yahooo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Abbas Rahimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation of Shahid  Beheshti University of Medical Science, Damavand Ave, Emam Hossein Sq</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1616913111</zip>
        <telephone>+98 21 7756 1721</telephone>
        <email>alikhoshdel97@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 20 to 40 years
With partial tear of Grade 1 and 2 Neer classification in supraspinatus tendon, with or without tearing in other rotator cuff tendons
Has partial tear of Grade 1 and 2 that has been confirmed by MRI
Positive at least two specific jobe supraspinatus test, Neer and hawkin kennedy
Partial tear of the supraspinatus muscle tendon with pain in the shoulder area for at least 3 months and up to one year.
Patients with a pain score of 5 or higher as determined by the visual analogue scale.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Full thickness tear in the supraspinatus tendon or Massive rupture in other rotator cuff tendons
History of surgery and implants in the shoulder area
History of steroid injection in the shoulder joint during the last six months
Rheumatoid arthritis
Diabetes
Neurological disorders
Hook-shaped acromion
Cases such as tumor, pregnancy, malignant tissue, infection, heat disturbance and people who have undergone radiotherapy in the last 6 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Intervention group: At the beginning of the treatment session, people undergoing cold therapy were placed on the shoulder area for 10 to 15 minutes using an ice pack. Then, in the first group, citing the World Laser Therapy Association (WALT) on the properties of the most effective low-power laser parameters in supraspinatus tendinopathy, under low-power IR laser therapy with a wavelength of 810 nm are significant. According to the proposed WALT protocol, the laser is applied at 2 to 3 points at the site of supraspinatus muscle tendon insertion and the former acromial space, with a high energy content of 4 gels per square meter, and generally 12 joules of energy during treatment. The patient's position is sitting and the hand is in the adduction position during the laser application. Pendulum exercises and range of motion improvements from the initial sessions, and isometric strengthening exercises from the fifth session, were added to the treatment program. in order to observe safety during laser treatment, although the risk of eye injury is small, precautions for using the laser are observed.</i_keyword>
      <i_keyword>Intervention group:Intervention group: At the beginning of the treatment session, people undergoing cryotherapy are placed on the shoulder region for 10 to 15 minutes using an ice pack. In this group, a laser with a power of 8 watts, energy of 12 joules per square centimeter and total energy of 10,000 joules will be used for about 15 minutes. The percussion of each pulse will be 150 microseconds and the frequency of 30 Hz in the first and third phases and the frequency of 25-25 Hz in the second phase will be used in an area of ​​25 cm2 during the three phases. The initial phase is applied in front of the shoulder joint line, with 850 mJ of energy per shot and at a frequency of 30 Hz. Total energy applied in this phase is equal to 4000 joules. In the second phase, the energy of each pulse is equal to 350 mJ and with a frequency of 20-25 Hz in front and behind the shoulder joint line. The total energy of this phase is equal to 4000 joules. In the third phase, which is applied in the same place as the first phase as well as the deltoid muscle areas, a total energy of 2000 joules is radiated. In general, the time required for laser treatment in all three phases of treatment will be about 15 minutes. And how to use the laser is rapid manual scanning. A spacer with a diameter of 35 mm will also be used to ensure a constant distance between the applicator and the skin during laser treatment. The patient's position during the laser application is sitting with the affected hand in the adduction position. Pendulum exercises and range of motion improvements from the initial sessions, and isometric strengthening exercises from the fifth session are added to the treatment program.  in order to observe safety during laser treatment, although the risk of eye injury is small, precautions for using the laser are observed.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Supraspinatus tendon thickness, Echogenicity of supraspinatus tendon. Timepoint: Before intervention, after 10 treatment sessions, eight weeks after the end of the treatment sessions follow up. Method of measurement: Ultrasonography imaging.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain intensity. Timepoint: Before intervention, after 10 treatment sessions, eight weeks after the end of the treatment sessions follow up. Method of measurement: Based on visual analogue scale.</sec_outcome>
      <sec_outcome>Shoulder abduction and adduction rang of motion. Timepoint: Before intervention, after 10 treatment sessions, eight weeks after the end of the treatment sessions follow up. Method of measurement: Using full circle goniometery.</sec_outcome>
      <sec_outcome>Shoulder flexion and extension rang of motion. Timepoint: Before intervention, after 10 treatment sessions, eight weeks after the end of the treatment sessions follow up. Method of measurement: Using full circle goniometery.</sec_outcome>
      <sec_outcome>Shoulder internal and external rotation rang of motion. Timepoint: Before intervention, after 10 treatment sessions, eight weeks after the end of the treatment sessions follow up. Method of measurement: Using full circle goniometery.</sec_outcome>
      <sec_outcome>Shoulder pain and disability. Timepoint: Before intervention, after 10 treatment sessions, eight weeks after the end of the treatment sessions follow up. Method of measurement: Using Shoulder pain and Disability index questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-11</approval_date>
        <contact_name>Ethics committee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>No. 7, west zayande rod Ave, north shirazi Ave, mollasadra Ave, vanak square Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
